YOKNEAM, Israel, Jan. 11, 2021 /PRNewswire/ — /PRNewswire/ — InMode Ltd. (Nasdaq: INMD), a leading global provider of innovative medical technologies, today announced its participation in the 2021 ICR Conference, which is being held virtually January 11-14, 2021. Shakil Lakhani, President of North America, and Dr. Spero Theodorou, M.D., Chief Medical Officer, will participate in a fireside chat on Thursday, January 14, 2021 at 3:15 pm EST.
A live webcast of the presentations will be available to the public at: https://inmodemd.com/investors/. The webcast will be archived for 90 days following the live presentation.
About InMode
InMode is a leading global provider of innovative medical technologies. InMode develops, manufactures, and markets devices harnessing novel radio-frequency (“RF”) technology. InMode strives to enable new emerging surgical procedures as well as improve existing treatments. InMode has leveraged its medically-accepted minimally-invasive RF technologies to offer a comprehensive line of products across several categories for plastic surgery, gynecology, dermatology, otolaryngology, and ophthalmology.
For more information about InMode, please visit www.inmodemd.com.
Investor Relations Contact:
Miri Segal-Scharia
MS-IR LLC
ir@inmodemd.com
917-607-8654
View original content:http://www.prnewswire.com/news-releases/inmode-to-participate-at-the-2021-icr-conference-301203598.html
SOURCE InMode Ltd.
KUALA LUMPUR, Malaysia, June 27, 2025 /PRNewswire/ -- Avio Health, a deep-tech company dedicated to advancing healthcare through data analytics and machine learning, today announced…
The 2025 Novo Nordisk Foundation Challenge Programme awards DKK 479 million to nine innovative projects that…
AMSTERDAM, June 26, 2025 /PRNewswire/ -- Vinamilk, Vietnam's leading dairy company, presented its science-driven innovation…
In the study of rare diseases and precision medicine, understanding gene expression in the spatial…
ARLINGTON, Va., June 26, 2025 /PRNewswire/ -- A new survey of 195 diagnostic imaging and…
FREMONT, Calif., June 26, 2025 /PRNewswire/ -- Ultima Genomics, a developer of an innovative new…